Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T03:51:29.513Z Has data issue: false hasContentIssue false
  • English
  • Français

Considerations for Inpatient Versus Outpatient Treatment with Antipsychotics

Published online by Cambridge University Press:  07 November 2014

David C. Henderson
Get accessRights & Permissions [Opens in a new window]

Extract

The general goals for recovery of patients with schizophrenia are relatively simple: to improve patients' functioning, enable them to return to work or school, and allow them resume normal lives. However, there are differences between inpatient and outpatient treatment as it relates to some of these goals. For example, a hospitalized patient who has just suffered an acute episode may not be able to realistically meet the abovementioned goals. In such cases, clinicians must try to meet more feasible goals: moving patients from an acute episode to remission, reducing symptoms, improving function, and achieving stability outside of the hospital (Slide 1). This road to recovery involves two phases of treatment, inpatient and outpatient, which differ in their pursuit of patient stability. This discussion will touch on some of the differences between inpatient and outpatient treatment as it relates to acute goals and successful long-term treatment.

Information

Type
Expert Roundtable Supplement
Information
CNS Spectrums , Volume 12 , Issue S21: Inpatient to Outpatient Status: Clinical Considerations in the Transitional Treatment of Schizophrenia , December 2007, pp. 3 - 5
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Andreasen, NC, Carpenter, WT Jr, Kane, JM, Lasser, RA, Marder, SR, Weinberger, DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162(3):441–449.Google Scholar
2.Robinson, DG, Woerner, MG, McMeniman, M, Mendelowitz, A, Bilder, RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004;161(3):473–479.Google Scholar
3.Robinson, D, Woerner, MG, Alvir, JM, et al.Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56(3);241–247.Google Scholar
4.American Psychiatric Association Practice Guidelines. Practice Guideline for the Treatment of Patients with Schizophrenia. 2nd ed. Arlington, Va: American Psychiatric Publishing, Inc.; 2004.Google Scholar
5.Leucht, S, Heres, S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry. 2006;67(Suppl 5):3–8.Google Scholar
6.Herings, RM, Erkens, JA. Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidemiol Drug Saf. 2003;12(5):423–424.Google Scholar
7.Hudson, TJ, Owen, RR, Thrush, CR, et al.A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry 2004;65(2):211–216.Google Scholar
8.Freudenreich, O, Deckersbach, T, et al.Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect. Acta Psychiatr Scand. 2004;110(1):14–20.Google Scholar
9.Marder, SR. Facilitating compliance with antipsychotic medication. J Clin Psychiatry 1998;59(Suppl 3):21–25.Google Scholar
10.Weiden, PJ, Mackell, JA, McDonnell, DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res. 2004;66(1):51–57.Google Scholar
11.American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care. 2004;27:596–601.Google Scholar
12.Goff, DC, Sullivan, LM, McEvoy, JP, et al.A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80(1):45–53.Google Scholar
13.Diaz, E, Neuse, E, Sullivan, MC, Pearsall, HR, Woods, SW. Adherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry. 2004;65(3):354–360.Google Scholar
14.Barbui, C, Biancosino, B, Esposito, E, Marmai, L, Donà, S, Grassi, L. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study. Int Clin Psychopharmacol. 2007;22(4):221–225.Google Scholar